Factors increasing the risk of mortality and morbidity due to coronavirus infection in patients with metabolic syndrome
Patients living with comorbid metabolic syndrome (MS) and metabolic disorders such as obesity and type 2 diabetes mellitus carry increased levels of circulating cytokines and systemic low-grade inflammation. Upon viral infection, such patients with all pre-existing backgrounds, specifically dysregul...
Main Authors: | Altansuvd Enkhtur, Joon-Sup Yoon, Chang-Woo Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Sungkyunkwan University School of Medi
2020-09-01
|
Series: | Precision and Future Medicine |
Subjects: | |
Online Access: | http://www.pfmjournal.org/upload/pdf/pfm-2020-00121.pdf |
Similar Items
-
Is the JAK-STAT Signaling Pathway Involved in the Pathogenesis of Depression?
by: Małgorzata Gałecka, et al.
Published: (2022-04-01) -
Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis
by: Ronan Talty, BS, et al.
Published: (2021-10-01) -
Embryonic hematopoiesis modulates the inflammatory response and larval hematopoiesis in Drosophila
by: Wael Bazzi, et al.
Published: (2018-07-01) -
Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review
by: Nem Kumar Jain, et al.
Published: (2023-03-01) -
Targeting JAK-STAT Signalling Alters PsA Synovial Fibroblast Pro-Inflammatory and Metabolic Function
by: Aisling O’Brien, et al.
Published: (2021-06-01)